BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
4.560
+0.040 (0.88%)
May 12, 2026, 12:29 PM EDT - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $7.56 million as of May 12, 2026. Its market cap has decreased by -70.64% in one year.
Market Cap
7.56M
Enterprise Value
6.57M
1-Year Change
-70.64%
Ranking
Category
Stock Price
$4.56
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $7.56M, a decrease of -99.92%. That is a compound annual growth rate of -73.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.49M | -77.65% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 8.33M |
| NuCana | 8.20M |
| Creative Medical Technology Holdings | 8.06M |
| Acurx Pharmaceuticals | 8.00M |
| PharmaCyte Biotech | 7.46M |
| Xenetic Biosciences | 7.19M |
| Can-Fite BioPharma | 7.18M |
| Processa Pharmaceuticals | 7.16M |